Search results

There are 101 search results for *.
March 29, 2018

Does managed competition constrain hospitals’ contract prices? Evidence from the Netherlands

In the Dutch health care system health insurers negotiate with hospitals about the pricing of hospital products in a managed competition framework. In this paper, we study these contract prices that became for the first time publicly available in 2016. The data show substantive price variation between hospitals for the same products, and within a hospital for the same product across insurers.

December 7, 2017

Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare

Since 2006, the Dutch population has faced two different cost-sharing schemes in health insurance for curative care: a mandatory rebate of 255 euros in 2006 and 2007, and since 2008 a mandatory deductible. Using administrative data for the entire Dutch population, we compare the effect of both cost-sharing schemes on healthcare consumption between 2006 and 2013.

December 7, 2017

Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare

Since 2006, the Dutch population has faced two different cost-sharing schemes in health insurance for curative care: a mandatory rebate of 255 euros in 2006 and 2007, and since 2008 a mandatory deductible. Using administrative data for the entire Dutch population, we compare the effect of both cost-sharing schemes on healthcare consumption between 2006 and 2013.

December 7, 2017

Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare

Since 2006, the Dutch population has faced two different cost-sharing schemes in health insurance for curative care: a mandatory rebate of 255 euros in 2006 and 2007, and since 2008 a mandatory deductible. Using administrative data for the entire Dutch population, we compare the effect of both cost-sharing schemes on healthcare consumption between 2006 and 2013.

October 12, 2017

Premium levels and demand response in health insurance: relative thinking and zero-price effects

In health care systems with a competitive health insurance market, governments or other sponsors (e.g. employers) often subsidize premiums to encourage enrolment. These subsidies are typically independent of plan choice leaving the absolute premium differences in place so as not to distort consumer choice of plan.

October 12, 2017

Premium levels and demand response in health insurance: relative thinking and zero-price effects

In health care systems with a competitive health insurance market, governments or other sponsors (e.g. employers) often subsidize premiums to encourage enrolment. These subsidies are typically independent of plan choice leaving the absolute premium differences in place so as not to distort consumer choice of plan.

May 18, 2017

De introductie van dure technologie in de zorg

Nieuwe medische technologie kan veel gezondheidswinst opleveren. Toch is niet altijd even duidelijk of en in welke mate er sprake is van gezondheidswinst.

May 18, 2017

De introductie van dure technologie in de zorg

Nieuwe medische technologie kan veel gezondheidswinst opleveren. Toch is niet altijd even duidelijk of en in welke mate er sprake is van gezondheidswinst.

May 18, 2017

De introductie van dure technologie in de zorg: analysekader en case studies

Adoptie van nieuwe medische technologie kan veel gezondheidswinst opleveren en op die manier bijdragen aan de kwaliteit van zorg. Maar de introductie van nieuwe technologie kan ook de zorgkosten opdrijven en daarmee de betaalbaarheid van zorg in gevaar brengen.

May 18, 2017

De introductie van dure technologie in de zorg: analysekader en case studies

Adoptie van nieuwe medische technologie kan veel gezondheidswinst opleveren en op die manier bijdragen aan de kwaliteit van zorg. Maar de introductie van nieuwe technologie kan ook de zorgkosten opdrijven en daarmee de betaalbaarheid van zorg in gevaar brengen.